scholarly article | Q13442814 |
P356 | DOI | 10.1007/S11547-017-0814-Y |
P698 | PubMed publication ID | 29019021 |
P50 | author | Rosario Francesco Grasso | Q38320349 |
Bruno Beomonte Zobel | Q41255525 | ||
P2093 | author name string | Federico Greco | |
Giovanni Muto | |||
Viola Giacobbe | |||
Domiziana Santucci | |||
Eliodoro Faiella | |||
Giulia Frauenfelder | |||
P2860 | cites work | Clinical and pathologic predictors of Gleason sum upgrading in patients after radical prostatectomy: results from a single institution series | Q84741524 |
[PI-RADS classification: structured reporting for MRI of the prostate] | Q86103564 | ||
Association of quantitative magnetic resonance imaging parameters with histological findings from MRI/ultrasound fusion prostate biopsy | Q86368088 | ||
Multiparametric MRI and targeted prostate biopsy: Improvements in cancer detection, localization, and risk assessment | Q26749212 | ||
Role of multiparametric magnetic resonance imaging in early detection of prostate cancer | Q26768765 | ||
The role of magnetic resonance imaging in the diagnosis and management of prostate cancer | Q26849794 | ||
PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2 | Q29037908 | ||
Cancer statistics, 2009 | Q29547625 | ||
Multiparametric Magnetic Resonance Imaging and Ultrasound Fusion Biopsy Detect Prostate Cancer in Patients with Prior Negative Transrectal Ultrasound Biopsies | Q30047599 | ||
Comparison of endorectal coil and nonendorectal coil T2W and diffusion-weighted MRI at 3 Tesla for localizing prostate cancer: correlation with whole-mount histopathology | Q33590993 | ||
Advances in magnetic resonance imaging: how they are changing the management of prostate cancer | Q33834982 | ||
MRI-ultrasound fusion for guidance of targeted prostate biopsy | Q34645142 | ||
Prognostic factors in prostate cancer | Q34682069 | ||
Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging | Q35354750 | ||
Imaging localized prostate cancer: current approaches and new developments. | Q36469177 | ||
Imaging prostate cancer: a multidisciplinary perspective | Q36773229 | ||
Assessment of the Performance of Magnetic Resonance Imaging/Ultrasound Fusion Guided Prostate Biopsy against a Combined Targeted Plus Systematic Biopsy Approach Using 24-Core Transperineal Template Saturation Mapping Prostate Biopsy. | Q36946259 | ||
Magnetic Resonance Imaging-Ultrasound Fusion-Guided Prostate Biopsy: Review of Technology, Techniques, and Outcomes | Q37055000 | ||
Update of prostate magnetic resonance imaging at 3 T. | Q37124315 | ||
Real-time MRI-TRUS fusion for guidance of targeted prostate biopsies | Q37149144 | ||
Optimal biopsy strategies for the diagnosis and staging of prostate cancer | Q37444009 | ||
Prostate cancer: multiparametric MR imaging for detection, localization, and staging. | Q37935483 | ||
The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System | Q38613858 | ||
Ultrasound guided transrectal core biopsies of the palpably abnormal prostate | Q39278520 | ||
Accuracy of biopsy Gleason scores from a large uropathology laboratory: use of a diagnostic protocol to minimize observer variability | Q39467128 | ||
Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting | Q39477975 | ||
The 20-core prostate biopsy protocol--a new gold standard? | Q39825591 | ||
Initial extended transrectal prostate biopsy--are more prostate cancers detected with 18 cores than with 12 cores? | Q39835651 | ||
Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up | Q40947941 | ||
How reliable is 12-core prostate biopsy procedure in the detection of prostate cancer? | Q41255229 | ||
Prostate cancer imaging | Q57392739 | ||
Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update | Q73328386 | ||
Outcomes for men with clinically nonmetastatic prostate carcinoma managed with radical prostactectomy, external beam radiotherapy, or expectant management: a retrospective analysis | Q74046131 | ||
Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer | Q77336558 | ||
Saturation prostate needle biopsy and prostate cancer detection at initial and repeat evaluation | Q80404952 | ||
P433 | issue | 2 | |
P304 | page(s) | 143-152 | |
P577 | publication date | 2017-10-10 | |
P1433 | published in | Radiologia medica, rivista mensile | Q26842258 |
P1476 | title | Analysis of histological findings obtained combining US/mp-MRI fusion-guided biopsies with systematic US biopsies: mp-MRI role in prostate cancer detection and false negative | |
P478 | volume | 123 |
Q90320403 | Correlation between ADC values and Gleason score in evaluation of prostate cancer: multicentre experience and review of the literature | cites work | P2860 |
Search more.